Endo International plc

Shareholder Alert: Robbins LLP Reminds Investors Endo International Plc (ENDP) Sued for Misleading Shareholders

Retrieved on: 
Thursday, July 16, 2020

Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Endo International Plc (NYSE: ENDP) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between August 8, 2017 and June 10, 2020.

Key Points: 
  • Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Endo International Plc (NYSE: ENDP) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between August 8, 2017 and June 10, 2020.
  • Endo manufactures and sells generic and branded pharmaceuticals in the U.S. and internally, including both generic and branded opioid products.
  • If you suffered a loss as a result of Endo's misconduct, click here .
  • On this news, Endo's stock price fell over 14% to close at $3.85.

Shareholder Alert: Robbins LLP Announces Endo International Plc (ENDP) Sued for Misleading Shareholders

Retrieved on: 
Saturday, June 27, 2020

Shareholder rights law firm Robbins LLP announces that a purchaser of Endo International Plc (NASDAQ: ENDP) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between August 8, 2017 and June 10, 2020.

Key Points: 
  • Shareholder rights law firm Robbins LLP announces that a purchaser of Endo International Plc (NASDAQ: ENDP) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between August 8, 2017 and June 10, 2020.
  • Endo manufactures and sells generic and branded pharmaceuticals in the U.S. and internally, including both generic and branded opioid products.
  • If you suffered a loss as a result of Endo's misconduct, click here .
  • On this news, Endo's stock price fell over 14% to close at $3.85.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Endo International plc Investors (ENDP)

Retrieved on: 
Monday, June 22, 2020

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP ) common stock between August 8, 2017 and June 10, 2020, inclusive (the Class Period).

Key Points: 
  • The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP ) common stock between August 8, 2017 and June 10, 2020, inclusive (the Class Period).
  • Endo investors have until August 18, 2020 to file a lead plaintiff motion.
  • According to the release, "The DFS' statement of charges alleges that, like other opioid manufacturers, Endo .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Endo International plc and Encourages Investors with Losses of $100,000 to Contact the Firm

Retrieved on: 
Monday, June 22, 2020

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Endo International plc (Endo or the Company) (NASDAQ: ENDP ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Endo International plc (Endo or the Company) (NASDAQ: ENDP ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • According to the DFS, it has filed charges and initiated administrative proceedings against Endo International plc and its subsidiaries, Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., and Par Pharmaceutical Companies, Inc.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Endo International plc (ENDP) on Behalf of Investors

Retrieved on: 
Monday, June 22, 2020

Law Offices of Howard G. Smith announces an investigation on behalf of Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP ) investors concerning the Company and its officers possible violations of federal securities laws.
  • According to the DFS press release, Endo .
  • On this news, the Companys share price fell $0.66, or nearly 15%, to close at $3.85 per share on June 10, 2020, thereby injuring investors.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Endo International plc Investors (ENDP)

Retrieved on: 
Friday, June 19, 2020

The Law Offices of Frank R. Cruz announces an investigation on behalf of Endo International plc (Endo or the Company) (NASDAQ: ENDP ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • The Law Offices of Frank R. Cruz announces an investigation on behalf of Endo International plc (Endo or the Company) (NASDAQ: ENDP ) investors concerning the Company and its officers possible violations of federal securities laws.
  • If you are a shareholder who suffered a loss, click here to participate.
  • On this news, the Companys share price fell $0.66, or nearly 15%, to close at $3.85 per share on June 10, 2020, thereby injuring investors.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Endo International plc and Encourages Investors with Losses of $100,000 to Contact the Firm

Retrieved on: 
Friday, June 19, 2020

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Endo International plc (Endo or the Company) (NASDAQ: ENDP ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Endo International plc (Endo or the Company) (NASDAQ: ENDP ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • According to the DFS, it has filed charges and initiated administrative proceedings against Endo International plc and its subsidiaries, Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., and Par Pharmaceutical Companies, Inc.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc - ENDP

Retrieved on: 
Thursday, June 18, 2020

NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Endo International plc (Endo or the Company) (NASDAQ:ENDP).

Key Points: 
  • NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Endo International plc (Endo or the Company) (NASDAQ:ENDP).
  • The investigation concerns whether Endo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • The DFS press release stated that [t]he DFS statement of charges alleges that, like other opioid Manufactures, Endo .
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference

Retrieved on: 
Thursday, May 14, 2020

DUBLIN, May 14, 2020 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020 at 9:10 a.m.

Key Points: 
  • DUBLIN, May 14, 2020 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020 at 9:10 a.m.
  • A live webcast and audio archive for the event will be available on the Company's website at http://investor.endo.com/events-and-presentations .
  • Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization.
  • Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.

Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference

Retrieved on: 
Thursday, May 14, 2020

DUBLIN, May 14, 2020 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020 at 9:10 a.m.

Key Points: 
  • DUBLIN, May 14, 2020 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020 at 9:10 a.m.
  • A live webcast and audio archive for the event will be available on the Company's website at http://investor.endo.com/events-and-presentations .
  • Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization.
  • Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.